// App-Quantinova.ai

PB2291 : STATUS OF IRREGULAR ANTIBODIES IN THE COVID ERA: A NEW PRESSURE FOR THE TRANSFUSION DEPARTMENT?

Researchers

Presenter

  • Harberth Fernandez Leyva

Principal Investigators

  • N/A

Medical Centers

  • Haematology,NHS,Licoln,United Kingdom

  • Haematology,NHS,Licoln,Vereinigtes Königreich

  • Haematology,NHS,Licoln,Reino Unido

  • Haematology,NHS,Licoln,Соединённое Королевство

  • Haematology,NHS,Licoln,Reino Unido

  • Haematology,NHS,Licoln,Storbritannien

  • Haematology,NHS,Licoln,Verenigd Koninkrijk

  • Haematology,NHS,Licoln,Royaume-uni

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cross-Sectional

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved